Ruane, Cunniff & Goldfarb’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-77,540
Closed -$1.33M 86
2017
Q1
$1.33M Sell
77,540
-9,834
-11% -$171K 0.01% 65
2016
Q4
$1.57M Sell
87,374
-100,956
-54% -$1.83M 0.01% 70
2016
Q3
$3.92M Hold
188,330
0.04% 60
2016
Q2
$5.06M Sell
188,330
-6,720
-3% -$184K 0.05% 54
2016
Q1
$5.29M Buy
195,050
+32,410
+20% +$868K 0.04% 63
2015
Q4
$4.72M Hold
162,640
0.03% 68
2015
Q3
$4.41M Sell
162,640
-960
-0.6% -$27.2K 0.02% 71
2015
Q2
$4.48M Sell
163,600
-500
-0.3% -$14.1K 0.02% 76
2015
Q1
$4.38M Sell
164,100
-284
-0.2% -$6.54K 0.02% 75
2014
Q4
$3.48M Buy
164,384
+13,100
+9% +$293K 0.02% 83
2014
Q3
$3.6M Sell
151,284
-169,700
-53% -$3.91M 0.02% 81
2014
Q2
$7.41M Sell
320,984
-164,276
-34% -$3.63M 0.04% 68
2014
Q1
$11.1M Sell
485,260
-136,680
-22% -$2.91M 0.06% 54
2013
Q4
$11.5M Buy
621,940
+230,080
+59% +$4.01M 0.06% 54
2013
Q3
$6.63M Buy
391,860
+45,460
+13% +$765K 0.04% 64
2013
Q2
$5.37M Buy
+346,400
New +$5.77M 0.03% 68

Other funds holding NVO